The Malaysian Health Coalition (MHC) has expressed disappointment over the government's decision to defer the second reading of the Tobacco Products and Smoking Control Bill, according to a report by the Malaysian Mail on October 17th.
The MHC has expressed its refusal to accept the government's reasons for postponing the submission process of the bill, which was originally scheduled for October 10. The organization stated, "We believe that this delay is a betrayal of the health of Malaysians." Additionally, they added that lawmakers concerned about tobacco control must raise their voices and oppose the delay.
We call on them to urge the government to respect the people's right to a smoke-free lifestyle. We also call on them to demonstrate their commitment to the World Health Organization's (WHO) endorsed Framework Convention on Tobacco Control, which Malaysia has already ratified.
Dr. Zaliha Mustafa, the Minister of Health, subsequently stated that the decision was made based on several suggestions put forward during recent meetings with government and non-governmental stakeholders, which need further consideration.
The Malaysian Health Coalition (MHC) states that the "Tobacco Products and Smoking Control Act" is a significant measure in Malaysia's efforts to address smoking and e-cigarette issues, which not only impact public health but also have implications for the country's economy, society, and environment.
We are deeply concerned about the current situation, which indicates that smoking and e-cigarettes continue to be a serious public health issue in Malaysia, particularly among adolescents and young adults.
According to data from the World Health Organization, approximately 20,000 people in Malaysia die each year from tobacco-related diseases. The smoking prevalence in Malaysia stands at 22.5%, with an additional 18% of teenagers reported as smokers.
It further stated, "Within this demographic, the use of e-cigarettes has also seen an increase, with approximately 15% of teenagers admitting to using e-cigarettes or similar nicotine substitute products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
